Sandra Ortiz-Cuaran will deliver the closing highlights session on basic and translational science at AACR26, according to Oncodaily.

The announcement names Ortiz-Cuaran as the presenter selected to close the American Association for Cancer Research's 2026 annual meeting with a summary of the year's most significant findings in basic and translational oncology research.

The feed item provides no further details on the specific studies, data sets, or trial results the session will cover. Oncodaily published the item as a headline notice rather than a full report, so researchers planning to attend or follow the session will need to wait for the meeting program for specifics on which abstracts the closing review will address.

AACR annual meeting closing sessions typically synthesize high-impact preclinical and early clinical work presented during the conference, and the selection of a presenter signals which research areas the organization considers the year's most consequential. Oncodaily identifies Ortiz-Cuaran's remit as spanning both basic mechanisms and translational application, a pairing that suggests the closing session will bridge laboratory discovery and clinical development.

No venue, date, or session time appears in the source item beyond the AACR26 designation. The Oncodaily piece also does not disclose who funded the session or whether the highlights will be published in summary form afterward.

Watch the AACR26 program release for the full session schedule and the list of studies the closing highlights will cover.